Articles
What You Need to Know About 340B Rebate Model
As HRSA’s new voluntary 340B Rebate Model Pilot Program deadline rapidly approaches, covered entities have fewer than four months to prepare for a fundamentally different financial and operational process. RxParadigm’s Tungsten+PLUS technology platform has existed for 4 years as an end-to-end rebate platform, now applied to MFP effectuation and incoming Rebate Model.
The 340B Rebate Model Pilot Program will begin for the original 10 drugs, plus 15 MFP drugs, switching 340B reimbursements from an upfront discount model to a rebate. 4 drugs are leaving MFP at the end of 2026, effectuation plans will reveal if these drugs are a part of the Rebate Model. The August 2026 Rebate Model Guideline does not vary significantly from the original guidance, proposed to begin January 2025.
In areas where CEs challenged HRSA’s stance, new Rebate Model documents shows that HRSA mostly adopted Manufacturers' views. For the selected drugs, Rebate Model applies to every dispense regardless of line of business (Commercial, Medicare, Medicaid, Uninsured). CEs will continue to buy and replenish under existing 340B wholesaler accounts, and pricing will convert to WAC.
Examples of allowable disputes include but do not seem limited to MFP duplication, and multiple CEs claiming same rebate. Upfront WAC purchase is no longer a prerequisite to submitting a rebate
Challenges of Rebate Model
The 25 selected drugs must now be bought at WAC, creating new cash flow and credit issues. Rebate payments are not 100% guaranteed and CEs need to have processes in place to dispute non-payments when appropriate
The handling related to administered drugs will also prove challenging. When there is Part D MFP and 340B overlap, who gets paid matters. MFP payments go to the Pharmacy, 340B Rebates go to the CE
The speed of 340B eligibility and submission now becomes critical across in-house and contract pharmacy. Finally, uninsured and under-insured programs will prove challenging for Rebate Model administration.
How Lessons from MFP Inform Rebate Model
RxParadigm has been supporting Hospitals, Clinics, health systems, FQHCs, and pharmacies in effectuation of MFP process since the program began in January of 2026. RxParadigm’s data spans all entity types, giving us a comprehensive look into the current state of the MFP process, from disputes to reconciliation.
Though the two programs differ, many MFP administration challenges will also occur in Rebate Model. Key lessons from MFP implementation include:
1) A Single Pane of Glass is Necessary. CEs need a single pane of glass dashboard to log and track multiple TPA systems, different claims, MTF for MFP, and Beacon for Rebate in a centralized way.
2) Manufacturer Vendor Systems Not Built for CEs. Manufacturer vendor systems have clear limitations that impact how the CE works, reporting efficiencies are lacking.
3) Rebate Administration Requires Experts. End-to-end rebate administration, dispute management and reconciliation requires additional expert resources.
4) Dispute Management is Costly and Time Consuming.
Rebate Model will require good faith disputes. GFI process is highly time consuming and requires automation.
5) Financial Process Requires Automation.
Reconciliation and tracking payment requires manual work or additional automation. Automation is necessary to manage work at scale.
Rebate Model Readiness
HRSA announced the new Rebate Model guidance on July 31st. Manufacturers must submit vendor plans by August 24th. HRSA makes approval decisions on September 24th, and the program goes live on January 1st, 2027. What actions should CEs take from August to January to get ready for Rebate Model?
1) Managing Multiple TPAs with 340B Data
CEs work with 2-7 TPAs for 340B data. In preparation of Rebate Model, CEs must manage 340B data accordingly.
2) Payment Reconciliation Across Systems
Determine how to reconcile payment files and ensure they are reflected appropriately in the financial system.
3) Dispute Management Workflow
Determine how to ramp up dispute management workflow, as existing teams will not be able to handle the volume of disputes.
4) Create Consolidated View of Reports
Find a way to manage reports from many different vendors and create a consolidated view of all Rebate activity.
The Tungsten+PLUS Advantage
Built by experts with more than 25 years of global rebate administration experience, Tungsten+PLUS™ has been refined and adapted for the emerging 340B Rebate Model. The platform is designed to respond quickly to evolving requirements—helping hospitals and health systems maintain financial control, protect cash flow, and minimize the risk of major revenue disruption.
Tungsten+PLUS™ delivers:
Real-time identification of eligible 340B claims
· Automated claim-data submission to manufacturers and their service providers
· Payment tracking and claim-level reconciliation
· Automated Dispute Management
· A single pane of glass view of all MFP and Rebate Model Activities
The Rebate Model may be new. Our technology, infrastructure, and expertise are not.
Conclusion
CEs must look for solutions that translate MFP readiness to Rebate Model readiness. Dispute resolution will be a major challenge, along with payment reconciliation and a consolidated view of Rebate Model activity.
RxParadigm has been implementing enhancements for Rebate Model. Our 340B Clearinghouse was built over 5 years and has the ability to adapt to any new Rebate Model components. Our Dispute Resolution Technology is at an advanced stage. Don’t try fitting a square peg in a round hole, invest in a solution custom fit for Rebate Model.
